252 related articles for article (PubMed ID: 29100943)
1. The avidity of cross-reactive virus-specific T cells for their viral and allogeneic epitopes is variable and depends on epitope expression.
van den Heuvel H; Heutinck KM; van der Meer-Prins EMW; Franke-van Dijk MEI; van Miert PPMC; Zhang X; Ten Berge IJM; Claas FHJ
Hum Immunol; 2018 Jan; 79(1):39-50. PubMed ID: 29100943
[TBL] [Abstract][Full Text] [Related]
2. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
[TBL] [Abstract][Full Text] [Related]
3. A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.
Yu Q; Zhang L; Ouyang L; Gong Y; Liang Z; Shen G; Weng X; Wu X
Immunogenetics; 2013 Mar; 65(3):173-84. PubMed ID: 23233149
[TBL] [Abstract][Full Text] [Related]
4. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
6. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
7. Infection with a virus generates a polyclonal immune response with broad alloreactive potential.
van den Heuvel H; van der Meer-Prins EMW; van Miert PPMC; Zhang X; Anholts JDH; Claas FHJ
Hum Immunol; 2019 Feb; 80(2):97-102. PubMed ID: 30773170
[TBL] [Abstract][Full Text] [Related]
8. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
D'Orsogna LJ; Amir AL; Zoet YM; van der Meer-Prins PM; van der Slik AR; Kester MG; Heemskerk MH; Doxiadis II; Roelen DL; Claas FH
Tissue Antigens; 2009 Oct; 74(4):290-7. PubMed ID: 19624615
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of HIV-specific T cell clonotypes using allogeneic HLA.
Almeida CA; van Miert P; O'Driscoll K; Zoet YM; Chopra A; Watson M; de Santis D; Witt C; John M; Claas FHJ; D'Orsogna LJ
Cell Immunol; 2017 Jun; 316():32-40. PubMed ID: 28372798
[TBL] [Abstract][Full Text] [Related]
10. Allo-HLA Cross-Reactivities of Cytomegalovirus-, Influenza-, and Varicella Zoster Virus-Specific Memory T Cells Are Shared by Different Healthy Individuals.
van den Heuvel H; Heutinck KM; van der Meer-Prins EMW; Yong SL; van Miert PPMC; Anholts JDH; Franke-van Dijk MEI; Zhang XQ; Roelen DL; Ten Berge RJM; Claas FHJ
Am J Transplant; 2017 Aug; 17(8):2033-2044. PubMed ID: 28332333
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
[TBL] [Abstract][Full Text] [Related]
12. Allo-HLA reactivity of virus-specific memory T cells is common.
Amir AL; D'Orsogna LJ; Roelen DL; van Loenen MM; Hagedoorn RS; de Boer R; van der Hoorn MA; Kester MG; Doxiadis II; Falkenburg JH; Claas FH; Heemskerk MH
Blood; 2010 Apr; 115(15):3146-57. PubMed ID: 20160165
[TBL] [Abstract][Full Text] [Related]
13. Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts.
Khorki ME; Shi T; Cianciolo EE; Burg AR; Chukwuma PC; Picarsic JL; Morrice MK; Woodle ES; Maltzman JS; Ferguson A; Katz JD; Baker BM; Hildeman DA
Front Immunol; 2023; 14():1287546. PubMed ID: 38143762
[TBL] [Abstract][Full Text] [Related]
14. Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-transfected K562 cells.
D'Orsogna LJ; van der Meer-Prins EM; Zoet YM; Roelen DL; Doxiadis II; Claas FH
Methods Mol Biol; 2012; 882():339-49. PubMed ID: 22665243
[TBL] [Abstract][Full Text] [Related]
15. Preferential HLA-B27 Allorecognition Displayed by Multiple Cross-Reactive Antiviral CD8
Rowntree LC; van den Heuvel H; Sun J; D'Orsogna LJ; Nguyen THO; Claas FHJ; Rossjohn J; Kotsimbos TC; Purcell AW; Mifsud NA
Front Immunol; 2020; 11():248. PubMed ID: 32140156
[TBL] [Abstract][Full Text] [Related]
16. Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.
van der Zwan A; van der Meer-Prins EMW; van Miert PPMC; van den Heuvel H; Anholts JDH; Roelen DL; Claas FHJ; Heidt S
Front Immunol; 2018; 9():2880. PubMed ID: 30574149
[TBL] [Abstract][Full Text] [Related]
17. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
[TBL] [Abstract][Full Text] [Related]
18. T Cell Cross-Reactivity between a Highly Immunogenic EBV Epitope and a Self-Peptide Naturally Presented by HLA-B*18:01+ Cells.
Rist MJ; Hibbert KM; Croft NP; Smith C; Neller MA; Burrows JM; Miles JJ; Purcell AW; Rossjohn J; Gras S; Burrows SR
J Immunol; 2015 May; 194(10):4668-75. PubMed ID: 25855358
[TBL] [Abstract][Full Text] [Related]
19. TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.
D'Orsogna LJ; Roelen DL; Doxiadis II; Claas FH
Immunogenetics; 2012 Feb; 64(2):77-85. PubMed ID: 22146829
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
